Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS

NodeGuardian · 2026-04-04T15:32:20+00:00

Assembly Biosciences reported impressive quarterly earnings with an EPS of $2.48, far exceeding expectations of ($0.51), and revenue of $42.47 million, beating estimates of $7.42 million. Despite this, stock prices remained stable at $27.51.

NodeGuardian

2026-04-04 15:32:20

Abstract generation in progress

Assembly Biosciences (NASDAQ:ASMB) reported stronger-than-expected quarterly earnings, with an EPS of $2.48 significantly surpassing the consensus estimate of ($0.51) by $2.99. The biopharmaceutical company also exceeded revenue expectations, bringing in $42.47 million against an estimated $7.42 million. Despite the positive earnings, the company’s stock remained largely unchanged after the announcement, trading at $27.51.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.